Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 USD | -0.93% | +21.08% | +164.26% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
Financials (USD)
Sales 2024 * | 13.74M | Sales 2025 * | 16.32M | Capitalization | 724M |
---|---|---|---|---|---|
Net income 2024 * | -115M | Net income 2025 * | -144M | EV / Sales 2024 * | 36.7 x |
Net cash position 2024 * | 221M | Net cash position 2025 * | 121M | EV / Sales 2025 * | 37 x |
P/E ratio 2024 * |
-6.11
x | P/E ratio 2025 * |
-5.35
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
1 day | -0.93% | ||
1 week | +21.08% | ||
Current month | +26.02% | ||
1 month | +19.31% | ||
3 months | +163.76% | ||
6 months | +229.38% | ||
Current year | +164.26% |
Managers | Title | Age | Since |
---|---|---|---|
Isabel Aznarez
FOU | Founder | 52 | 14-05-31 |
Edward Kaye
CEO | Chief Executive Officer | 75 | 17-09-30 |
Barry Ticho
CTO | Chief Tech/Sci/R&D Officer | 64 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 15-08-31 |
Edward Kaye
CEO | Chief Executive Officer | 75 | 17-09-30 |
Seth Harrison
CHM | Chairman | 63 | 15-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 13.9 | -0.93% | 471,156 |
24-05-16 | 14.03 | -0.71% | 762,680 |
24-05-15 | 14.13 | +10.39% | 1,305,308 |
24-05-14 | 12.8 | +10.82% | 955,192 |
24-05-13 | 11.55 | +0.61% | 264,123 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.26% | 724M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- STOK Stock